StockMacro
Menu

Ingevity

$53.75 -22% in 6 monthsMarket cap $1.8B

NGVT on XNYS, Materials, Ingevity Corporation, job postings

Measures activity, not value. Not investment advice.

Revenue fell 8.4% last quarter while institutional holders rose 10% to 340.

  • WatchShares down 24% in one month, up 13% over 12 months
  • BadRevenue down 6.5% over 12 months to $1.1B

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.

Industry
Chemicals & allied products (Materials)
Employees
1,500
Website
ingevity.com
Listed
NYSE, US
Last results
4 Nov 2026
Next results
expected around 24 Feb 2027 (an estimate: a year ago it reported on 25 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $305.1M, net income $49.3M.
Quarter to 31 Dec 2021: revenue $336.0M, net income $29.3MQuarter to 31 Dec 2021: revenue $336.0M, net income $29.3MQuarter to 31 Mar 2022: revenue $382.8M, net income $60.8MQuarter to 31 Mar 2022: revenue $382.8M, net income $60.8MQuarter to 30 Jun 2022: revenue $419.9M, net income $59.8MQuarter to 30 Jun 2022: revenue $419.9M, net income $59.8MQuarter to 30 Sep 2022: revenue $482.0M, net income $75.4MQuarter to 30 Sep 2022: revenue $482.0M, net income $75.4MQuarter to 31 Dec 2022: revenue $383.6M, net income $15.6MQuarter to 31 Dec 2022: revenue $383.6M, net income $15.6MQuarter to 31 Mar 2023: revenue $392.6M, net income $50.7MQuarter to 31 Mar 2023: revenue $392.6M, net income $50.7MQuarter to 30 Jun 2023: revenue $481.8M, net income $35.5MQuarter to 30 Jun 2023: revenue $481.8M, net income $35.5MQuarter to 30 Sep 2023: revenue $446.0M, net income $25.2MQuarter to 30 Sep 2023: revenue $446.0M, net income $25.2MQuarter to 31 Dec 2023: revenue $371.7M, net income -$116.8MQuarter to 31 Dec 2023: revenue $371.7M, net income -$116.8MQuarter to 31 Mar 2024: revenue $340.1M, net income -$56.0MQuarter to 31 Mar 2024: revenue $340.1M, net income -$56.0MQuarter to 30 Jun 2024: revenue $390.6M, net income -$283.7MQuarter to 30 Jun 2024: revenue $390.6M, net income -$283.7MQuarter to 30 Sep 2024: revenue $376.9M, net income -$107.2MQuarter to 30 Sep 2024: revenue $376.9M, net income -$107.2MQuarter to 31 Dec 2024: revenue $298.8M, net income $16.6MQuarter to 31 Dec 2024: revenue $298.8M, net income $16.6MQuarter to 31 Mar 2025: revenue $284.0M, net income $20.5MQuarter to 31 Mar 2025: revenue $284.0M, net income $20.5MQuarter to 30 Jun 2025: revenue $365.1M, net income -$146.5MQuarter to 30 Jun 2025: revenue $365.1M, net income -$146.5MQuarter to 30 Sep 2025: revenue $333.1M, net income $43.5MQuarter to 30 Sep 2025: revenue $333.1M, net income $43.5MQuarter to 31 Dec 2025: revenue –, net income -$84.6MQuarter to 31 Mar 2026: revenue $258.0M, net income $59.8MQuarter to 31 Mar 2026: revenue $258.0M, net income $59.8MQuarter to 30 Jun 2026: revenue $314.1M, net income $35.3MQuarter to 30 Jun 2026: revenue $314.1M, net income $35.3MQuarter to 30 Sep 2026: revenue $305.1M, net income $49.3MQuarter to 30 Sep 2026: revenue $305.1M, net income $49.3M
31 Dec 2021RevenueNet incomeNet losstallest bar $482.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$305.1M$49.3M
30 Jun 2026$314.1M$35.3M
31 Mar 2026$258.0M$59.8M
31 Dec 2025–-$84.6M
30 Sep 2025$333.1M$43.5M
30 Jun 2025$365.1M-$146.5M
31 Mar 2025$284.0M$20.5M
31 Dec 2024$298.8M$16.6M
30 Sep 2024$376.9M-$107.2M
30 Jun 2024$390.6M-$283.7M
31 Mar 2024$340.1M-$56.0M
31 Dec 2023$371.7M-$116.8M
30 Sep 2023$446.0M$25.2M
30 Jun 2023$481.8M$35.5M
31 Mar 2023$392.6M$50.7M
31 Dec 2022$383.6M$15.6M
30 Sep 2022$482.0M$75.4M
30 Jun 2022$419.9M$59.8M
31 Mar 2022$382.8M$60.8M
31 Dec 2021$336.0M$29.3M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.1B $1.2B
Revenue growthRevenue of the last 12 months compared with the 12 months before. -6.5% -0.3%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $59.8M -$65.9M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $1.73 -$1.82
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 42.0% 39.3% 22.0%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -2.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 5.3% -5.4% 1.3%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 59.5% 1.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $122.6M $239.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $85.4M $83.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $1.1B $1.3B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $1.1B $1.2B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 18.2 0.81
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $1.86
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 30.4 29.8
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.6 1.1
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 2.5 1.4
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 28.8 2.5

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
IngevityNGVT (this company) $1.8B30.41.6-6.5%5.3%
InnospecIOSP $1.9B13.30.99+4.7%7.5%
OlinOLN $1.7Bloss0.26-0.7%-3.3%
ChemoursCC $1.6Bloss0.28+0.1%-2.6%
HuntsmanHUN $1.5Bloss0.26-4.7%-5.8%
EcovystECVT $977.5M27.11.0+45%3.7%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+10%

340 13F filers vs 308

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

34.7M shares held by 13F filers (30 Sep 2026) of 33.8M outstanding (3 Nov 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.7%

1.3M shares sold short (30 Oct 2026) of 33.8M outstanding (3 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.4

1.3M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-8.2%

1.4M shares sold short in the report before, 1.3M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

36%

36% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 55%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-8.4%

$305.1M vs $333.1M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+15%

$13.7M vs $11.9M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$110K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

8

8 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

8.0×

8 articles in the last 7 days; its usual week has 1.

Price $53.75 on 20 Nov 2026, +13% over 12 months (12-month range $47.48 to $77.87)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $1.8M in the last 12 months (the 12 months before: $0).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months, 0% on the 12 months before.
Revenue per quarter. Revenue $305.1M in the latest quarter, -8.4% on a year earlier.
Capital spending per quarter. Capital spending $13.7M in the latest quarter, +15% on a year earlier.
Institutional holders (13F filers). 340 13F filers reported holding it in the latest 13F quarter, +20% on a year earlier.
Lobbying spend. Lobbying spend: $110K published in the last 12 months, -67% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
24 Jun 20268-K and other filingsDirector or officer change
4 May 20268-K and other filingsDirector or officer change
23 Feb 20268-K and other filingsDirector or officer change
5 Jan 20268-K and other filingsCompleted an acquisition or asset sale
8 Dec 20258-K and other filingsDirector or officer change
23 Oct 20258-K and other filingsDirector or officer change
23 Oct 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Jul 2025Sharp changeLobbying on a new issue: lobbying on a new issue: AGR (2025-06-30)
1 Jul 20258-K and other filingsDirector or officer change
1 May 20258-K and other filingsDirector or officer change
10 Mar 20258-K and other filingsDirector or officer change
16 Dec 20248-K and other filingsDirector or officer change
3 Oct 20248-K and other filingsDirector or officer change
3 Oct 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
31 Jul 20248-K and other filingsRestructuring costs announced
8 Jul 20248-K and other filingsA major agreement ended
1 Jul 20248-K and other filingsDirector or officer change
1 Jul 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Mar 20248-K and other filingsDirector or officer change
14 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 Jan 2024Sharp changeLobbying on a new issue: lobbying on a new issue: CHM (2023-12-31)
1 Nov 20238-K and other filingsRestructuring costs announced
20 Jul 2023Sharp changeLobbying on a new issue: lobbying on a new issue: TRD (2023-06-30)
18 Jul 2023Sharp changeShort interest spike: short interest spike, 1.3M vs usual 849K (2023-06-30); 1.5x the same period a year earlier
24 Mar 20238-K and other filingsCompleted an acquisition or asset sale
21 Feb 20238-K and other filingsDirector or officer change
21 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Nov 2022Sharp changeQuarterly revenue change: quarterly revenue change, 482.0M vs usual 347.2M (2022-09-30); 1.3x the same period a year earlier
3 Oct 20228-K and other filingsCompleted an acquisition or asset sale
27 Jul 20228-K and other filingsDirector or officer change
27 Jul 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 Feb 20228-K and other filingsDirector or officer change
9 Dec 20218-K and other filingsDirector or officer change
9 Dec 2021Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2022: -$194K published
Month from 1 Mar 2023: -$1.2M published
Month from 1 Jun 2026: -$34K published
Month from 1 Aug 2026: -$1.7M published
H-1B/E-3 applications certified
Quarter from 1 Apr 2022: 1 published
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Apr 2023: 1 published
Quarter from 1 Oct 2023: 1 published
Quarter from 1 Jan 2024: 1 published
Quarter from 1 Jul 2025: 1 published
Quarter from 1 Apr 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $336.0M, +3.2% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $382.8M, +20% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $419.9M, +17% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $482.0M, +28% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $383.6M, +14% on a year earlier; public on 1 Mar 2023
Quarter ended 31 Mar 2023: $392.6M, +2.6% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $481.8M, +15% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $446.0M, -7.5% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $371.7M, -3.1% on a year earlier; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $340.1M, -13% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $390.6M, -19% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $376.9M, -15% on a year earlier; public on 31 Oct 2024
Quarter ended 31 Dec 2024: $298.8M, -20% on a year earlier; public on 20 Feb 2025
Quarter ended 31 Mar 2025: $284.0M, -16% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $365.1M, -6.5% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $333.1M, -12% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Mar 2026: $258.0M, -9.2% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $314.1M, -14% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $305.1M, -8.4% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $37.4M; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $27.6M, +62% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $29.6M, +24% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $36.1M, +42% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $49.2M, +32% on a year earlier; public on 1 Mar 2023
Quarter ended 31 Mar 2023: $25.4M, -8.0% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $21.7M, -27% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $33.5M, -7.2% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $29.2M, -41% on a year earlier; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $16.6M, -35% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $18.1M, -17% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2024: $18.0M, -46% on a year earlier; public on 31 Oct 2024
Quarter ended 31 Dec 2024: $24.9M, -15% on a year earlier; public on 20 Feb 2025
Quarter ended 31 Mar 2025: $10.0M, -40% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $12.2M, -33% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $11.9M, -34% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $23.6M, -5.2% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $10.3M, +3.0% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $10.3M, -16% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $13.7M, +15% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 250; public on 14 Feb 2022
31 Mar 2022 report: 255; public on 16 May 2022
30 Jun 2022 report: 244; public on 15 Aug 2022
30 Sep 2022 report: 244; public on 14 Nov 2022
31 Dec 2022 report: 261; public on 14 Feb 2023
31 Mar 2023 report: 257; public on 15 May 2023
30 Jun 2023 report: 226; public on 14 Aug 2023
30 Sep 2023 report: 237; public on 14 Nov 2023
31 Dec 2023 report: 235; public on 14 Feb 2024
31 Mar 2024 report: 249; public on 15 May 2024
30 Jun 2024 report: 255; public on 14 Aug 2024
30 Sep 2024 report: 253; public on 14 Nov 2024
31 Dec 2024 report: 251; public on 14 Feb 2025
31 Mar 2025 report: 267; public on 15 May 2025
30 Jun 2025 report: 256; public on 14 Aug 2025
30 Sep 2025 report: 283; public on 14 Nov 2025
31 Dec 2025 report: 290; public on 17 Feb 2026
31 Mar 2026 report: 297; public on 15 May 2026
30 Jun 2026 report: 308; public on 14 Aug 2026
30 Sep 2026 report: 340; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $90K published
Quarter from 1 Apr 2022: $110K published
Quarter from 1 Jul 2022: $110K published
Quarter from 1 Oct 2022: $110K published
Quarter from 1 Jan 2023: $110K published
Quarter from 1 Apr 2023: $110K published
Quarter from 1 Jul 2023: $110K published
Quarter from 1 Oct 2023: $110K published
Quarter from 1 Jan 2024: $110K published
Quarter from 1 Apr 2024: $110K published
Quarter from 1 Jul 2024: $110K published
Quarter from 1 Oct 2024: $110K published
Quarter from 1 Jan 2025: $110K published
Quarter from 1 Apr 2025: $110K published
Quarter from 1 Jul 2025: $110K published
Quarter from 1 Oct 2026: $110K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $765K (18 Aug 2026), 6.3× its normal reading; higher than 90% of its own history.
  • Insider net buying (open market): Insiders sold a net $1.8M in the last 12 months (the 12 months before: $0).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 1 published in the last 12 months, 0% on the 12 months before.
  • Revenue per quarter: Revenue $305.1M in the latest quarter, -8.4% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 25 insider trades

No trades in the last 90 days; the latest was filed 18 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
18 Aug 2026David H LiPresident & CEOSellplanned in advance (10b5-1)10,092$75.77$765KForm 4
14 Aug 2026David H LiPresident & CEOSellplanned in advance (10b5-1)10,000$76.17$762KForm 4
4 Aug 2026Ryan C. FisherSVP, Gen. Counsel & SecretarySell2,709$73.72$200KForm 4
1 Jun 2026Terrance M DyerSVP, Chief HR OfficerSell496$68.49$34KForm 4
8 Mar 2023Richard Allen White JrSVP, Perf Chem and Pres, ISPTSell1,439$81.00$117KForm 4
6 Mar 2023Phillip John PlattCAO & VP, Bus Transform LeadSellafter exercising options8,847$81.71$723KForm 4
6 Mar 2023Stuart Edward Woodcock Jr.EVP and Pres, Perf MaterialsSell4,968$82.14$408KForm 4
6 Dec 2022Erik Spencer RippleChief Growth and Innovation OfSell856$77.84$67KForm 4

340 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 54 opened a position, 28 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.5.2M15.5%$371.3M-116K-2.2%
Vanguard Portfolio Management LLC2.4M7.20%$172.0M+54K+2.3%
Vanguard Capital Management LLC1.6M4.62%$110.4M-11K-0.7%
State Street Corp1.4M4.26%$101.8M-59K-3.9%
American Century Companies Inc1.4M4.06%$96.9M+99K+7.8%
Brown Advisory Inc1.0M3.05%$72.8M+55K+5.6%
Segall Bryant & Hamill, LLC1.0M2.99%$71.4M-46K-4.3%
Geode Capital Management, LLC907K2.69%$64.2M-12K-1.3%
Wellington Management Group LLP879K2.60%$62.2M-196K-18%
Royce & Associates LP864K2.56%$61.1M-77K-8.2%

Company events

All 55 company events

In 12 months: 4 director or officer changes, 2 major agreements, 1 completed deal. Results releases and routine reports are left out.

FiledWhat happenedSource
24 Jun 2026Director or officer change8-K
4 May 2026Director or officer changeSame filing: shareholder vote results8-K
30 Mar 2026Signed a major agreementSame filing: took on new debt8-K
23 Feb 2026Director or officer change8-K
5 Jan 2026Signed a major agreement; Completed an acquisition or asset sale8-K
8 Dec 2025Director or officer change8-K
23 Oct 2025Director or officer change8-K
4 Sep 2025Signed a major agreement8-K

Reported lobbying spend: $110K in Q3 2026, $110K in Q2 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
10 Jun 2021NewTaft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka (Taft, Stettinius & Hofor Ingevity CorporationInfrastructure PolicyRODFiling
3 Jul 2019EndedAjw, Inc.for Ingevity CorporationNot statedFiling
13 Mar 2019NewHolland & Knight LLPfor Ingevity CorporationAlternative fuel vehicles.FUEFiling
13 Nov 2018NewAjw, Inc.for Ingevity CorporationEPA rulemaking on GHG emissions and fuel economy standards for light duty vehiclesAUT, EnvironmentFiling

The 5 newest of 61 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

20 Jul 2023confirmed

Confirmed across sources Lobbying and Short interest and volume

Ingevity (NGVT): had 1.3M shares sold short in the 30 Jun 2023 report, 1.5× the same report last year, while it lobbying on a new issue. Two unrelated kinds of activity within 1 day.

  • Short interest and volume: Short interest spike, became public on 13 Jul 2023
  • Lobbying: Lobbying on a new issue, became public on 20 Jul 2023
2022-06-30: 882K2022-07-15: 907K2022-07-29: 983K2022-08-15: 848K2022-08-31: 803K2022-09-15: 941K2022-09-30: 781K2022-10-14: 953K2022-10-31: 845K2022-11-15: 711K2022-11-30: 617K2022-12-15: 664K2022-12-30: 690K2023-01-13: 712K2023-01-31: 779K2023-02-15: 936K2023-02-28: 948K2023-03-15: 913K2023-03-31: 864K2023-04-14: 896K2023-04-28: 850K2023-05-15: 673K2023-05-31: 799K2023-06-15: 1.0M2023-06-30: 1.3M
The 30 Jun 2023 report against the 24 reports before it. this reportearliernormal: 849K
See the evidence (2 changes)

Short interest and volume: Short interest spike became public on 13 Jul 2023

Ingevity had 1.3M shares sold short in the 30 Jun 2023 report, 1.5× the same report last year.

This period
1.3M (the 30 Jun 2023 report)
Normal report (median of 24 earlier)
849K
Typical spread (median absolute deviation)
79K
How far from its usual level
+3.9
Same report last year
882K
History used
2,009 days
2022-06-30: 882K2022-07-15: 907K2022-07-29: 983K2022-08-15: 848K2022-08-31: 803K2022-09-15: 941K2022-09-30: 781K2022-10-14: 953K2022-10-31: 845K2022-11-15: 711K2022-11-30: 617K2022-12-15: 664K2022-12-30: 690K2023-01-13: 712K2023-01-31: 779K2023-02-15: 936K2023-02-28: 948K2023-03-15: 913K2023-03-31: 864K2023-04-14: 896K2023-04-28: 850K2023-05-15: 673K2023-05-31: 799K2023-06-15: 1.0M2023-06-30: 1.3M
the 30 Jun 2023 report24 earlier reportsnormal: 849K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying on a new issue became public on 20 Jul 2023

Ingevity lobbying on a new issue.

New
['TRD']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12728529

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

31 Mar 2020confirmed

Confirmed across sources Insiders and Short interest and volume

Ingevity (NGVT): had 4 insiders buy $734K of its shares on the open market within 30 days (4 filings), while it had 1.7M shares sold short in the 13 Mar 2020 report, 2.8× the same report last year. Two unrelated kinds of activity within 27 days.

  • Insiders: Clustered insider buying, became public on 4 Mar 2020
  • Short interest and volume: Short interest spike, became public on 25 Mar 2020
2019-03-15: 604K2019-03-29: 555K2019-04-15: 510K2019-04-30: 535K2019-05-15: 488K2019-05-31: 558K2019-06-14: 653K2019-06-28: 805K2019-07-15: 914K2019-07-31: 855K2019-08-15: 790K2019-08-30: 833K2019-09-13: 993K2019-09-30: 1.1M2019-10-15: 1.1M2019-10-31: 982K2019-11-15: 1.1M2019-11-29: 1.1M2019-12-13: 1.0M2019-12-31: 1.0M2020-01-15: 1.0M2020-01-31: 1.0M2020-02-14: 1.0M2020-02-28: 1.1M2020-03-13: 1.7M
The 13 Mar 2020 report against the 24 reports before it. this reportearliernormal: 948K
See the evidence (2 changes)

Insiders: Clustered insider buying became public on 4 Mar 2020

Ingevity had 4 insiders buy $734K of its shares on the open market within 30 days (4 filings).

Independent buyers
4
Purchase filings (Form 4, code P)
4
Total bought
$734K
Window
3 Feb 2020 to 4 Mar 2020

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 25 Mar 2020

Ingevity had 1.7M shares sold short in the 13 Mar 2020 report, 2.8× the same report last year.

This period
1.7M (the 13 Mar 2020 report)
Normal report (median of 24 earlier)
948K
Typical spread (median absolute deviation)
127K
How far from its usual level
+4.1
Same report last year
604K
History used
805 days
2019-03-15: 604K2019-03-29: 555K2019-04-15: 510K2019-04-30: 535K2019-05-15: 488K2019-05-31: 558K2019-06-14: 653K2019-06-28: 805K2019-07-15: 914K2019-07-31: 855K2019-08-15: 790K2019-08-30: 833K2019-09-13: 993K2019-09-30: 1.1M2019-10-15: 1.1M2019-10-31: 982K2019-11-15: 1.1M2019-11-29: 1.1M2019-12-13: 1.0M2019-12-31: 1.0M2020-01-15: 1.0M2020-01-31: 1.0M2020-02-14: 1.0M2020-02-28: 1.1M2020-03-13: 1.7M
the 13 Mar 2020 report24 earlier reportsnormal: 948K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 24 Jun 2026Filings record

    Director or officer change

  2. 4 May 2026Filings record

    Director or officer change

  3. 23 Feb 2026Filings record

    Director or officer change

  4. 5 Jan 2026Filings record

    Completed an acquisition or asset sale

  5. 8 Dec 2025Filings record

    Director or officer change

  6. 23 Oct 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 23 Oct 2025Filings record

    Director or officer change

  8. 18 Jul 2025Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['AGR']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12730460
  9. 1 Jul 2025Filings record

    Director or officer change

  10. 1 May 2025Filings record

    Director or officer change

  11. 10 Mar 2025Filings record

    Director or officer change

  12. 16 Dec 2024Filings record

    Director or officer change

  13. 3 Oct 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 3 Oct 2024Filings record

    Director or officer change

  15. 31 Jul 2024Filings record

    Restructuring costs announced

  16. 8 Jul 2024Filings record

    A major agreement ended

  17. 1 Jul 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 1 Jul 2024Filings record

    Director or officer change

  19. 14 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 14 Mar 2024Filings record

    Director or officer change

  21. 23 Jan 2024Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['CHM']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12729350
  22. 1 Nov 2023Filings record

    Restructuring costs announced

  23. 20 Jul 2023several at once

    had 1.3M shares sold short in the 30 Jun 2023 report, 1.5× the same report last year, while it lobbying on a new issue. Two unrelated kinds of activity within 1 day.

    See the evidence (2 changes)

    Short interest and volume: Short interest spike became public on 13 Jul 2023

    Ingevity had 1.3M shares sold short in the 30 Jun 2023 report, 1.5× the same report last year.

    This period
    1.3M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    849K
    Typical spread (median absolute deviation)
    79K
    How far from its usual level
    +3.9
    Same report last year
    882K
    History used
    2,009 days
    2022-06-30: 882K2022-07-15: 907K2022-07-29: 983K2022-08-15: 848K2022-08-31: 803K2022-09-15: 941K2022-09-30: 781K2022-10-14: 953K2022-10-31: 845K2022-11-15: 711K2022-11-30: 617K2022-12-15: 664K2022-12-30: 690K2023-01-13: 712K2023-01-31: 779K2023-02-15: 936K2023-02-28: 948K2023-03-15: 913K2023-03-31: 864K2023-04-14: 896K2023-04-28: 850K2023-05-15: 673K2023-05-31: 799K2023-06-15: 1.0M2023-06-30: 1.3M
    the 30 Jun 2023 report24 earlier reportsnormal: 849K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Lobbying: Lobbying on a new issue became public on 20 Jul 2023

    Ingevity lobbying on a new issue.

    New
    ['TRD']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12728529

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  24. 20 Jul 2023Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['TRD']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12728529
  25. 13 Jul 2023Short interest and volume change

    had 1.3M shares sold short in the 30 Jun 2023 report, 1.5× the same report last year.

    Same report last year: 882K; its normal report is 849K.

    See the evidence
    This period
    1.3M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    849K
    Typical spread (median absolute deviation)
    79K
    How far from its usual level
    +3.9
    Same report last year
    882K
    History used
    2,009 days
    2022-06-30: 882K2022-07-15: 907K2022-07-29: 983K2022-08-15: 848K2022-08-31: 803K2022-09-15: 941K2022-09-30: 781K2022-10-14: 953K2022-10-31: 845K2022-11-15: 711K2022-11-30: 617K2022-12-15: 664K2022-12-30: 690K2023-01-13: 712K2023-01-31: 779K2023-02-15: 936K2023-02-28: 948K2023-03-15: 913K2023-03-31: 864K2023-04-14: 896K2023-04-28: 850K2023-05-15: 673K2023-05-31: 799K2023-06-15: 1.0M2023-06-30: 1.3M
    the 30 Jun 2023 report24 earlier reportsnormal: 849K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 24 Mar 2023Filings record

    Completed an acquisition or asset sale

  27. 21 Feb 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 21 Feb 2023Filings record

    Director or officer change

  29. 8 Nov 2022Financials change

    reported revenue of $482.0M for the quarter ended 30 Sep 2022, 1.3× the same quarter last year.

    Same quarter last year: $376.8M; its normal quarter is $347.2M.

    See the evidence
    This period
    $482.0M (the quarter ended 30 Sep 2022)
    Normal quarter (median of 8 earlier)
    $347.2M
    Typical spread (median absolute deviation)
    $24.2M
    How far from its usual level
    +3.7
    Same quarter last year
    $376.8M
    History used
    2,740 days
    2020-09-30: $331.7M2020-12-31: $325.6M2021-03-31: $320.3M2021-06-30: $358.4M2021-09-30: $376.8M2021-12-31: $336.0M2022-03-31: $382.8M2022-06-30: $419.9M2022-09-30: $482.0M
    the quarter ended 30 Sep 20228 earlier quartersnormal: $347.2M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  30. 3 Oct 2022Filings record

    Completed an acquisition or asset sale

  31. 27 Jul 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 27 Jul 2022Filings record

    Director or officer change

  33. 23 Feb 2022Filings record

    Director or officer change

  34. 9 Dec 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 9 Dec 2021Filings record

    Director or officer change

  36. 20 Jul 2021Lobbying record

    INGEVITY CORPORATION: new lobbying registration (TAFT STETTINIUS & HOLLISTER LLP DBA TAFT ADVISORS LLC FKA (TAFT, STETTINIUS & HO) (dated 10 Jun 2021)

  37. 20 Apr 2021Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['ROD']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12722443
  38. 24 Mar 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 24 Mar 2021Filings record

    Director or officer change

  40. 24 Aug 2020Filings record

    Director or officer change

Showing the newest 40 of 75 entries; narrow the window or the kind of data to see older ones.

Not listed: 137 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001653477
Ticker
NGVT
Domain
ingevity.com
Employer name
Ingevity Corporation (1 unverified)
Hq location
SC|NORTH CHARLESTON|29405 (1 unverified)
Lobbying client
ingevity
Name
Ingevity Arkansas, LLC, Ingevity Australia Pty Ltd, Ingevity Corporation, Ingevity Georgia, LLC and 16 more
  • DOL H-1B labor condition applications and PERM certifications68 data points23 Dec 2019 to 14 Sep 2026
  • Federal lobbying disclosures (LDA)4 records, 84 data points13 Nov 2018 to 30 Sep 2026
  • SEC Form 13F institutional holdings378 data points30 Jun 2016 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)159 records26 Apr 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)845 data points31 Dec 2013 to 3 Nov 2026
  • SEC Form 4 insider transactions25 records, 80 data points16 May 2017 to 18 Aug 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026